News
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026
EMA ·
The Brief
- The EMA's CHMP recommended seven new medicines for approval at its 9-12 November 2026 meeting.
- Meeting highlights were published by the EMA on 2026-11-13.
- Recommendations are non-binding; final marketing authorisation decisions rest with the European Commission.
Why it matters
Science readers tracking European drug approvals can see which new treatments are moving toward authorisation in the EU, though the source provides no details on the individual medicines.
Who’s affected
- patients and clinicians in the European Union
- pharmaceutical researchers and industry analysts
- #medicines
- #regulation
- #european medicines agency
- #drug approval
- #chmp
Seven new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended seven medicines for approval at its November 2026 meeting.The committee…, CHMP statistics Key figures from the November 2026 CHMP meeting are represented in the graphic below. ©…
Timeline
CHMP meeting begins (9-12 November 2026)
CHMP recommends seven new medicines for approval
EMA publishes meeting highlights
News and press releases
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026